In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Area of interest 1 selected

Area of interest

Type

Type

Guidance programme

Showing 1 to 9 of 9

TitleTypeExpected publication date
Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen ID6462Technology appraisal guidanceTBC
Drug-eluting coronary stents for treating coronary artery disease: late-stage assessmentHealth technology evaluation
Fenfluramine for treating seizures associated with Lennox–Gastaut syndrome in people 2 years and over [ID1651]Technology appraisal guidanceTBC
Intrapartum care - uterotonics for postpartum haemorrhageNICE guideline
Molnupiravir for treating COVID 19 [ID6340]Technology appraisal guidance
Pegcetacoplan for treating geographic atrophy [ID4041]Technology appraisal guidanceTBC
Pegylated liposomal irinotecan in combination for untreated metastatic pancreatic cancer [ID6461]Technology appraisal guidanceTBC
Seladelpar for previously treated primary biliary cholangitis ID6429Technology appraisal guidanceTBC
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease [ID3821]Technology appraisal guidanceTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All